Uss Investment Management LTD Alnylam Pharmaceuticals, Inc. Transaction History

Uss Investment Management LTD

$12.3 Billion
Q2 2024

A detailed history of Uss Investment Management LTD transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, Uss Investment Management LTD holds 36,847 shares of ALNY stock, worth $10.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares

36,847

Previous 35,414 4.05%

Holding current value

$10.1 Million

Previous $5.29 Million 69.18%

% of portfolio

0.07%

Previous 0.04%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$143.31 - $247.0 $205,363 - $353,951	1,433 Added 4.05%	36,847 $8.95 Million
Q1 2024 May 15, 2024	BUY	$146.51 - $198.2 $543,845 - $735,718	3,712 Added 11.71%	35,414 $5.29 Million
Q4 2023 Feb 14, 2024	SELL	$151.41 - $196.57 $382,915 - $497,125	-2,529 Reduced 7.39%	31,702 $6.07 Million
Q3 2023 Nov 14, 2023	BUY	$170.77 - $211.65 $718,258 - $890,199	4,206 Added 14.01%	34,231 $6.06 Million
Q1 2023 May 12, 2023	SELL	$182.66 - $235.53 $220,835 - $284,755	-1,209 Reduced 3.87%	30,025 $6.01 Million
Q4 2022 Feb 13, 2023	SELL	$185.53 - $241.31 $8.45 Million - $11 Million	-45,569 Reduced 59.33%	31,234 $7.42 Million
Q3 2022 Nov 08, 2022	SELL	$138.54 - $232.0 $50,290 - $84,216	-363 Reduced 0.47%	76,803 $15.4 Million
Q2 2022 Aug 12, 2022	SELL	$120.42 - $169.29 $336,694 - $473,334	-2,796 Reduced 3.5%	77,166 $11.3 Million
Q1 2022 May 13, 2022	BUY	$127.18 - $173.91 $536,953 - $734,248	4,222 Added 5.57%	79,962 $13.1 Million
Q3 2021 Nov 15, 2021	BUY	$169.75 - $207.73 $3.21 Million - $3.92 Million	18,882 Added 33.21%	75,740 $14.3 Million
Q2 2021 Aug 10, 2021	BUY	$128.63 - $176.89 $6.42 Million - $8.83 Million	49,900 Added 717.16%	56,858 $9.64 Million
Q2 2020 Aug 11, 2020	BUY	$104.21 - $156.44 $725,093 - $1.09 Million	6,958 New	6,958 $1.03 Million

Others Institutions Holding ALNY

# of Institutions

614

Shares Held

108M

Call Options Held

2.33M

Put Options Held

2.17M

View Full List

About ALNYLAM PHARMACEUTICALS, INC.

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $33.8B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

More about ALNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Uss Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Uss Investment Management LTD with notifications on news.

Account

Uss Investment Management LTD Alnylam Pharmaceuticals, Inc. Transaction History